RecallDepth
Class II Terminated

Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.

Company
Nostrum Laboratories Inc
Recall Initiated
March 6, 2020
Posted
April 1, 2020
Recall Number
D-1059-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4722 bottles
Firm Location
Kansas City, MO, United States

Reason for Recall

CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.

Distribution

TN, MO

Lot / Code Info

Lot: THE190501, Exp 11/2022

More recalls by Nostrum Laboratories Inc

View all recalls by this company →

Other recent Class II Drug recalls